Max Healthcare Institute Ltd

Max Healthcare Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Max Healthcare Institute Ltd

₹ 945 -1.49%
02 Apr - close price
maxhealthcare.in BSE: 543220 NSE: MAXHEALTH
About

Max Healthcare Institute Limited is primarily engaged in the providing healthcare services through primary care clinics, multi-speciality hospitals / medical centres and super-speciality hospitals providing operation and management, medical services, clinical, radiology, pathology services and related healthcare services. [1]

Key Points

Leadership[1]
The company is India’s largest hospital chain in terms of market cap and 2nd largest hospital in terms of revenue and EBITDA.

Website BSE NSE
  • Market Cap ₹ 91,928 Cr.
  • Current Price ₹ 945
  • High / Low ₹ 1,314 / 929
  • Stock P/E 131
  • Book Value ₹ 87.3
  • Dividend Yield 0.16 %
  • ROCE 12.5 %
  • ROE 9.45 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 203% CAGR over last 5 years
  • Company has been maintaining a healthy dividend payout of 18.7%

Cons

  • Stock is trading at 10.8 times its book value
  • Company has a low return on equity of 9.70% over last 3 years.
  • Earnings include an other income of Rs.293 Cr.
  • Debtor days have increased from 33.1 to 40.5 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of Nifty 50 BSE 500 BSE Healthcare BSE 100 BSE 200

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
482 507 544 597 591 610 621 686 697 659 694 737 711
328 354 384 394 391 407 423 461 461 484 506 523 507
Operating Profit 154 154 160 203 200 203 198 225 236 175 188 214 204
OPM % 32% 30% 29% 34% 34% 33% 32% 33% 34% 27% 27% 29% 29%
44 41 43 48 43 134 43 134 18 98 80 47 68
Interest 13 14 14 13 10 15 8 8 23 9 9 9 11
Depreciation 28 30 28 28 30 32 30 32 33 36 35 37 36
Profit before tax 157 151 161 210 203 291 203 318 198 227 223 216 225
Tax % 22% 16% 22% 23% 22% 17% 24% 27% 30% 22% 26% 26% 17%
122 126 126 161 158 242 154 231 138 177 166 160 187
EPS in Rs 1.26 1.30 1.30 1.66 1.63 2.49 1.59 2.38 1.42 1.82 1.71 1.65 1.92
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
591 790 912 984 1,059 1,008 59 1,031 1,775 1,905 2,341 2,664 2,800
615 768 890 941 1,048 976 65 870 1,332 1,321 1,579 1,830 2,020
Operating Profit -24 22 22 43 11 31 -6 161 443 584 762 833 780
OPM % -4% 3% 2% 4% 1% 3% -10% 16% 25% 31% 33% 31% 28%
39 33 35 30 51 47 66 -104 128 144 271 293 293
Interest 42 43 30 35 41 44 60 112 59 52 52 48 38
Depreciation 31 49 50 51 49 53 3 91 112 113 117 131 144
Profit before tax -58 -38 -24 -13 -28 -18 -3 -146 400 563 865 947 891
Tax % 0% 0% -0% 0% 0% 26% -5% 12% 17% -23% 21% 26%
-58 -38 -24 -13 -28 -23 -3 -164 332 694 687 701 691
EPS in Rs -1.46 -0.78 -0.44 -0.24 -0.51 -0.43 -0.06 -1.70 3.42 7.15 7.07 7.21 7.10
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 14% 21% 21%
Compounded Sales Growth
10 Years: 13%
5 Years: 114%
3 Years: 14%
TTM: 7%
Compounded Profit Growth
10 Years: 36%
5 Years: 203%
3 Years: 32%
TTM: -14%
Stock Price CAGR
10 Years: %
5 Years: 33%
3 Years: 30%
1 Year: -17%
Return on Equity
10 Years: 6%
5 Years: 8%
3 Years: 10%
Last Year: 9%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 395 489 533 537 537 537 537 966 970 971 972 972 972
Reserves 167 523 762 770 773 749 2,338 4,973 5,342 6,071 6,709 7,317 7,523
505 296 273 314 386 390 658 480 556 534 443 612 705
223 141 171 210 278 274 20 724 945 845 945 1,065 1,176
Total Liabilities 1,290 1,449 1,740 1,832 1,973 1,951 3,553 7,143 7,812 8,420 9,069 9,967 10,376
468 430 424 429 502 479 90 2,989 4,493 4,485 4,717 4,871 4,890
CWIP 10 15 6 30 7 10 0 8 60 103 235 277 345
Investments 238 451 840 866 799 770 2,471 2,379 1,447 1,475 1,915 2,614 2,613
574 554 469 508 665 693 992 1,766 1,811 2,358 2,202 2,206 2,527
Total Assets 1,290 1,449 1,740 1,832 1,973 1,951 3,553 7,143 7,812 8,420 9,069 9,967 10,376

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
39 64 33 52 -19 -36 219 447 696 613 598
-200 -330 -66 -89 55 -2,536 -84 -670 -843 -806 -873
176 251 34 36 -36 2,332 397 -161 -54 -246 -29
Net Cash Flow 15 -16 0 -0 -0 -240 532 -384 -201 -438 -304
Free Cash Flow -15 42 -47 -7 -66 -39 189 78 579 156 344
CFO/OP 223% 338% 93% 573% -35% 467% 122% 111% 134% 100% 94%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 97 67 48 55 68 103 517 109 56 27 32 40
Inventory Days 18 20 18 19 22 25 33 20 31 24 20
Days Payable 158 171 183 206 250 335 297 159 226 225 191
Cash Conversion Cycle -42 -85 -117 -132 -161 -206 517 -155 -83 -169 -169 -130
Working Capital Days -54 -15 -33 -20 -27 14 -493 27 5 -45 -32 -24
ROCE % 0% 1% 1% 2% 2% 4% 7% 9% 12% 13%

Insights

In beta
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
ALOS (Average Length of Stay)
Days

Log in to view insights

Please log in to see hidden values.

Login
ARPOB (Average Revenue Per Occupied Bed)
INR '000
Occupancy Percentage
%
Bed Capacity (Network)
Number
Outpatient (OP) Consultations
Lakhs
Operating EBITDA per bed (Annualised)
INR Lakhs

Shareholding Pattern

Numbers in percentages

2 Recently
Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
23.77% 23.76% 23.76% 23.75% 23.75% 23.74% 23.74% 23.74% 23.74% 23.74% 23.74% 23.72%
51.96% 59.89% 60.39% 60.69% 57.33% 56.99% 57.29% 56.93% 54.74% 54.76% 51.80% 50.55%
19.36% 11.90% 11.40% 11.55% 14.96% 15.36% 15.14% 15.55% 17.59% 17.41% 20.03% 21.20%
4.92% 4.45% 4.45% 3.99% 3.97% 3.91% 3.84% 3.77% 3.94% 4.09% 4.43% 4.52%
No. of Shareholders 1,04,6561,11,3741,18,6351,11,3381,27,0091,36,2541,37,8561,40,0281,51,6331,62,1191,80,8912,03,837

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls